Quetiapine edges out rival antipsychotics in Alzheimer’s behavioral symptoms, with far fewer movement side effects
A meta-analysis of 25 randomized controlled trials in Alzheimer's disease finds quetiapine associated with lower odds of treatment failure than ...
